Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The audit was completed with zero critical and zero major observations
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The new site enables end-to-end production of viral vector gene therapies
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
The cGMP-4 facility will further strengthen the company's ability to serve global partners
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Subscribe To Our Newsletter & Stay Updated
